Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.